Cabot (CBT) Q2 2026 Margin Compression Reinforces Bearish Earnings Narratives

Cabot Corporation

Cabot Corporation

CBT

0.00

Cabot (CBT) just posted its Q2 2026 scorecard, with revenue of US$904 million and basic EPS of US$1.31, alongside trailing 12 month revenue of US$3.6 billion and EPS of US$5.31 that sit against a net margin of 7.8%. Over the past year of reported quarters, revenue has ranged between US$849 million and US$955 million while quarterly EPS has moved between US$0.79 and US$1.87, giving investors a clear view of how the top line and per share earnings have tracked into this latest print. With net margin now below the 10.9% level reported a year earlier, the focus around these results is increasingly on how much earnings power the company can sustain from each sales dollar.

See our full analysis for Cabot.

With the numbers on the table, the next step is to see how this earnings profile lines up with the prevailing narratives around Cabot, and where those stories might need to be updated.

NYSE:CBT Revenue & Expenses Breakdown as at May 2026
NYSE:CBT Revenue & Expenses Breakdown as at May 2026

Margins Under Pressure at 7.8%

  • Trailing net margin sits at 7.8% versus 10.9% a year earlier, while trailing net income is US$280 million on US$3.6b of revenue.
  • Bears highlight the weaker margin profile, and the numbers give them material support:
    • Trailing 12 month EPS moved from US$7.81 in Q2 2025 to US$5.31 in Q2 2026, alongside the margin step down from 10.9% to 7.8%.
    • Quarterly net income has also been uneven, ranging from US$42 million to US$100 million across the last six reported quarters, which aligns with concerns about earnings volatility.

EPS Swings Across Recent Quarters

  • Over the last six reported quarters, basic EPS has ranged from US$0.79 to US$1.87 while quarterly revenue stayed in a tighter band of US$849 million to US$955 million.
  • What stands out for a cautious view is how earnings move more than sales, which fits a bearish angle on profit sensitivity:
    • Q2 2026 EPS of US$1.31 and Q1 2026 EPS of US$1.37 follow Q4 2025 at US$0.79 and Q3 2025 at US$1.87, showing earnings per share can shift sharply even when revenue is clustered around US$900 million.
    • Trailing 12 month EPS at US$5.31 is also lower than the US$7.73 reading in Q3 2025, which backs worries that recent earnings momentum has cooled compared with the earlier five year earnings growth history.

Valuation And Income Versus Slower Growth

  • The stock trades on a 15.2x P/E at a share price of US$81.28, about 20.6% below a DCF fair value of roughly US$102.31, while offering a 2.33% dividend yield.
  • Bulls point to this combination as support, but the trailing growth profile gives a more mixed picture:
    • Revenue has grown at 3.1% per year on a trailing basis, which sits alongside the drop in net margin from 10.9% to 7.8%, so valuation support is arriving at a time when profitability has softened.
    • Five year earnings growth of 25.8% per year contrasts with negative earnings growth in the most recent year, which means the lower P/E and gap to DCF fair value may be reflecting this shift rather than ignoring it.

Bulls who think the current P/E discount and dividend yield outweigh the recent margin and earnings trends may want to see how that view stacks up across different scenarios in the wider community discussions Curious how numbers become stories that shape markets? Explore Community Narratives.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Cabot's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

If this mix of pressure and potential feels finely balanced, move quickly to review the full picture for yourself by using the 2 key rewards and 1 important warning sign.

See What Else Is Out There

Cabot's softer 7.8% net margin, volatile EPS and recent negative earnings growth contrast with its earlier five year earnings growth history and support a more cautious stance.

If that mix of earnings swings and softer profitability feels uncomfortable, check out the 72 resilient stocks with low risk scores to focus on companies with more resilient profiles and potentially steadier returns.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.